Therapeutic benefit of vaso-active drugs
โ
A K Burroughs; D Patch
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 190 KB
five days. The primary outcome measure was survival without rebleeding five days after sclerotherapy. Re- ## DEFINITIONS IN TRIALS? sults. After five days, the proportion of patients who had Levacher S, Letoumelin P, Pateron D, Blaise M, Lopandry survived without rebleeding was higher in the octr